ADIPOQ and type 2 diabetes mellitus: In the current study, we assessed adiponectin and NO levels in patients with type 2 diabetes mellitus (group I) and people without type 2 diabetes mellitus (group II) and found that adiponectin levels and NO levels were significantly lower in group I when compared to group II, and there was a significant negative correlation between adiponectin, NO levels, and FBS in group I.